Last reviewed · How we verify
Fruquintinib in Combination with Sintilimab
At a glance
| Generic name | Fruquintinib in Combination with Sintilimab |
|---|---|
| Also known as | Fruquintinib |
| Sponsor | Hutchmed |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Fruquintinib in Combination with Sintilimab CI brief — competitive landscape report
- Fruquintinib in Combination with Sintilimab updates RSS · CI watch RSS
- Hutchmed portfolio CI